It is estimated that nearly half of Americans adults have some form of cardiovascular disease.[1] These diseases include diabetes, hypertension, obesity, coronary artery disease, amyloidosis, myocarditis, cardiomyopathy, and many others. Without the ability to test for the effects of chronic diseases early and initiate preventative cardiac treatment, the progression of dysfunction goes unnoticed until cardiac symptoms occur.[2]
MyoStrain® helps physicians identify at-risk patients before symptoms occur by providing visibility into the early progression of myocardial dysfunction across chronic disease states.[3] Physicians may be able to use a proactive management approach to address at-risk patients early and prevent cardiac adverse events.
56% of heart failure patients go undiagnosed until after being hospitalized for an adverse event.[4] In order to prevent heart failure, especially in those with a history of chronic disease and/or risk factors, physicians must be able to identify and address at-risk patients at the earliest point of care.
MyoStrain provides a rapid, accurate and non-invasive heart function assessment to help physicians detect early dysfunction and start early treatment. Through this enhanced primary care approach, physicians are better equipped to manage patient heart health at an earlier stage and monitor the individual effects of treatment on their patients.
56% of heart failure patients go undiagnosed until after being hospitalized for an adverse event.[4] In order to prevent heart failure, especially in those with a history of chronic disease and/or risk factors, physicians must be able to identify and address at-risk patients at the earliest point of care.
MyoStrain provides a rapid, accurate and non-invasive heart function assessment to help physicians detect early dysfunction and start early treatment. Through this enhanced primary care approach, physicians are better equipped to manage patient heart health at an earlier stage and monitor the individual effects of treatment on their patients.
56% of heart failure patients go undiagnosed until after being hospitalized for an adverse event.[4] In order to prevent heart failure, especially in those with a history of chronic disease and/or risk factors, physicians must be able to identify and address at-risk patients at the earliest point of care.
MyoStrain provides a rapid, accurate and non-invasive heart function assessment to help physicians detect early dysfunction and start early treatment. Through this enhanced primary care approach, physicians are better equipped to manage patient heart health at an earlier stage and monitor the individual effects of treatment on their patients.
[1] Cardiovascular diseases affect nearly half of American adults, statistics show. American Heart Association. www.heart.org. (n.d.). [2] What is Heart Failure? American Heart Association. https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure. [3] Korosoglou, G et al. J Am Coll Cardiol Cardiovasc Imaging. Jan 13, 2021. DOI: 10.1016/j.jcmg.2020.10.024. [4] Dunlay, SM, et al. Limetime costs of medical care after heart failure diagnosis. Circulation Cardiovascular Qual Outcomes. 2011;4(1):68-75.
